Anuli Aesthetics & Weightloss

Anuli Aesthetics & Weightloss operates in Houston, Texas, providing medical weight loss programs centered on GLP-1 receptor agonist peptides and metabolic support therapies. The clinic's board-certified providers design individualized protocols that address the physiological mechanisms underlying weight gain, insulin resistance, and metabolic dysfunction. Patients access both in-person consultations at the Houston facility and telehealth appointments, allowing flexibility for those across Texas seeking physician-supervised weight management without requiring repeated office visits for routine follow-ups.

The clinic's peptide therapy menu includes Semaglutide and Tirzepatide, two glucagon-like peptide-1 receptor agonists that regulate appetite, slow gastric emptying, and improve glycemic control. Semaglutide protocols typically begin at lower doses with gradual titration based on patient tolerance and weight loss response, while Tirzepatide incorporates dual GIP and GLP-1 receptor activity for patients who may benefit from enhanced metabolic effects. NAD+ (nicotinamide adenine dinucleotide) supplementation complements these peptide protocols by supporting cellular energy production, mitochondrial function, and metabolic efficiency. Providers at Anuli Aesthetics & Weightloss adjust peptide dosing schedules and NAD+ administration routes—whether subcutaneous, intramuscular, or intravenous—based on individual patient labs, body composition analysis, and weight loss trajectory.

The board-certified medical team conducts comprehensive intake assessments that include metabolic panel review, body composition measurement, and discussion of previous weight loss attempts to identify barriers such as hormonal imbalances, medication side effects, or underlying conditions affecting metabolism. Each patient receives a structured plan outlining peptide administration schedules, expected timelines for dose adjustments, nutritional guidance aligned with peptide mechanisms, and protocols for managing common side effects like nausea or gastrointestinal changes during the initial titration phase. The clinic's approach emphasizes patient education on how GLP-1 agonists alter hunger signaling and satiety pathways, enabling informed participation in the treatment process.

Patients beginning Semaglutide or Tirzepatide at Anuli Aesthetics & Weightloss attend an initial consultation where providers review medical history, current medications, contraindications, and realistic weight loss expectations based on clinical data. Follow-up appointments—conducted in-person or via telehealth—occur at intervals aligned with dose escalation schedules, typically every four weeks during the titration phase. The clinic provides injection training for patients self-administering subcutaneous peptides at home, along with written protocols for reconstitution if applicable, proper refrigeration, and needle disposal. Patients receive direct access to clinical staff for questions about injection technique, side effect management, or concerns between scheduled appointments, ensuring continuity of care throughout the weight loss program.

Anuli Aesthetics & Weightloss distinguishes itself through its dual-modality access model, allowing Houston-area patients to choose in-person visits for hands-on assessments and body composition tracking while offering telehealth for routine check-ins, prescription refills, and protocol adjustments. This hybrid structure accommodates patients with demanding schedules or those traveling within Texas who require consistent medical oversight without geographic constraints. The clinic's integration of NAD+ therapy alongside GLP-1 peptides addresses the cellular energy deficits that can accompany caloric restriction, potentially reducing fatigue and supporting sustained adherence to weight loss protocols. With 139 patient reviews reflecting a 4.9-star rating, the clinic's documented patient feedback highlights responsiveness to questions, clarity in explaining medication mechanisms, and structured goal-setting processes that align clinical interventions with individual weight loss targets.